Clorox reorganizes leadership: Hyder becomes COO, Barton shifts to strategy
The Clorox Company simplifies its structure by promoting Chris Hyder to chief operating officer and reassigning Nina Barton to lead growth and strategy.
By the FiledFeed automated desk
This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.
The short version
Clorox announced an organizational restructuring on June 17, 2026, in which Chris Hyder was appointed executive vice president and chief operating officer, consolidating oversight of all business units. Nina Barton moved into the newly created role of chief growth and strategy officer, focusing on innovation and portfolio shaping. The changes are intended to streamline operations and accelerate growth.
Filing impact
Filing sentiment
Clorox announced a simplified operating structure on June 17, 2026, designed to reduce complexity and improve execution across the company.
Chris Hyder, who previously led the Health & Hygiene business unit (which includes Health & Wellness and International segments), has been promoted to executive vice president and chief operating officer, effective immediately. In the new role, Hyder will oversee all business units and drive end-to-end execution across the enterprise.
Nina Barton, the former group president of Care & Connection (which oversaw Household and Lifestyle segments), has been appointed executive vice president and chief growth and strategy officer. In this role, she will focus on innovation, value superiority, strategy, and portfolio shaping to position the company for faster growth. Commercial functions will report to Barton, creating what the company says will be a more integrated approach to meeting consumer trends.
CEO Linda Rendle said the restructured leadership is part of the company's broader "IGNITE strategy" and will help Clorox move faster and deliver stronger results, particularly as it focuses investment on faster-growing health and hygiene categories. Rendle also noted that Hyder brings more than two decades of experience at Clorox and a strong track record of accelerating performance, while Barton brings brand-building expertise and growth focus.
The board is continuing its search for a new CEO, announced on May 28, 2026.
Why it matters
The reshuffle consolidates operational control under a single executive (Hyder as COO) while shifting Nina Barton from line management to a strategy-focused role. This signals Clorox's intent to clarify accountability for execution while keeping strategic planning and portfolio decisions at the executive level. The changes come as the company completes a CEO transition and pursues its IGNITE transformation strategy, with an explicit focus on reallocating capital toward higher-growth health and hygiene categories—suggesting management believes the company's future growth lies there, not in its Household and Lifestyle segments.
Frequently asked
- What new roles did Chris Hyder and Nina Barton receive?
- Chris Hyder was appointed executive vice president and chief operating officer, overseeing all business units. Nina Barton was appointed executive vice president and chief growth and strategy officer, focusing on innovation, strategy, and portfolio shaping.
- When did these leadership changes take effect?
- Chris Hyder's appointment as chief operating officer was effective immediately on June 17, 2026. The filing does not specify an effective date for Nina Barton's new role, though it is announced concurrently.
- What business units did Hyder and Barton previously lead?
- Chris Hyder previously led the Health & Hygiene business unit (including Health & Wellness and International segments). Nina Barton previously led the Care & Connection business unit (including Household and Lifestyle segments).
- Is Clorox still searching for a new CEO?
- Yes. The board announced on May 28, 2026, that it is conducting a comprehensive CEO search with a leading firm to identify a new CEO.
What the filing reported
- 5.02 Departure/Election of Directors or Officers
- 7.01 Regulation FD Disclosure
- 9.01 Financial Statements & Exhibits
Source
Based on CLOROX CO /DE/'s 8-K filed with the SEC on Jun 17, 2026. Read the original filing on SEC.gov ↗